nodes	percent_of_prediction	percent_of_DWPC	metapath
Raloxifene—CYP19A1—gestational diabetes	0.969	1	CbGaD
Raloxifene—EBP—uterus—gestational diabetes	0.00365	0.122	CbGeAlD
Raloxifene—AOX1—islet of Langerhans—gestational diabetes	0.00188	0.0626	CbGeAlD
Raloxifene—SIGMAR1—islet of Langerhans—gestational diabetes	0.00151	0.0503	CbGeAlD
Raloxifene—HTR6—head—gestational diabetes	0.00136	0.0453	CbGeAlD
Raloxifene—ESR1—embryo—gestational diabetes	0.00129	0.043	CbGeAlD
Raloxifene—ESR2—uterus—gestational diabetes	0.00127	0.0424	CbGeAlD
Raloxifene—AOX1—uterus—gestational diabetes	0.00122	0.0408	CbGeAlD
Raloxifene—AOX1—adipose tissue—gestational diabetes	0.0012	0.0399	CbGeAlD
Raloxifene—ESR2—vagina—gestational diabetes	0.00103	0.0345	CbGeAlD
Raloxifene—CYP19A1—uterus—gestational diabetes	0.001	0.0334	CbGeAlD
Raloxifene—AOX1—vagina—gestational diabetes	0.000994	0.0332	CbGeAlD
Raloxifene—SIGMAR1—uterus—gestational diabetes	0.000984	0.0328	CbGeAlD
Raloxifene—HTR2B—uterus—gestational diabetes	0.000982	0.0328	CbGeAlD
Raloxifene—CYP19A1—adipose tissue—gestational diabetes	0.000979	0.0327	CbGeAlD
Raloxifene—SIGMAR1—adipose tissue—gestational diabetes	0.000963	0.0321	CbGeAlD
Raloxifene—HTR2B—adipose tissue—gestational diabetes	0.000961	0.032	CbGeAlD
Raloxifene—ESR2—head—gestational diabetes	0.000954	0.0318	CbGeAlD
Raloxifene—ESR1—uterus—gestational diabetes	0.00087	0.029	CbGeAlD
Raloxifene—ESR1—adipose tissue—gestational diabetes	0.000851	0.0284	CbGeAlD
Raloxifene—SIGMAR1—vagina—gestational diabetes	0.0008	0.0267	CbGeAlD
Raloxifene—HTR2B—vagina—gestational diabetes	0.000798	0.0266	CbGeAlD
Raloxifene—CYP19A1—head—gestational diabetes	0.000752	0.0251	CbGeAlD
Raloxifene—HTR2B—head—gestational diabetes	0.000738	0.0246	CbGeAlD
Raloxifene—ESR1—vagina—gestational diabetes	0.000707	0.0236	CbGeAlD
Raloxifene—ESR1—head—gestational diabetes	0.000654	0.0218	CbGeAlD
Raloxifene—CYP2C8—vagina—gestational diabetes	0.000583	0.0194	CbGeAlD
Raloxifene—CYP2B6—vagina—gestational diabetes	0.000523	0.0174	CbGeAlD
Raloxifene—CYP2B6—head—gestational diabetes	0.000483	0.0161	CbGeAlD
Raloxifene—ESR2—Ovarian Infertility Genes—CYP19A1—gestational diabetes	7.53e-05	0.0653	CbGpPWpGaD
Raloxifene—ESR2—Nuclear Receptors—AR—gestational diabetes	6.38e-05	0.0554	CbGpPWpGaD
Raloxifene—AOX1—Tryptophan metabolism—CYP19A1—gestational diabetes	6.13e-05	0.0532	CbGpPWpGaD
Raloxifene—AOX1—Defective AMN causes hereditary megaloblastic anemia 1—NAMPT—gestational diabetes	5.07e-05	0.044	CbGpPWpGaD
Raloxifene—ESR2—Nuclear Receptor transcription pathway—AR—gestational diabetes	5.04e-05	0.0438	CbGpPWpGaD
Raloxifene—ESR1—Leptin signaling pathway—LEPR—gestational diabetes	3.83e-05	0.0332	CbGpPWpGaD
Raloxifene—ESR1—Nuclear Receptors—AR—gestational diabetes	3.22e-05	0.0279	CbGpPWpGaD
Raloxifene—CYP19A1—Biological oxidations—GGCT—gestational diabetes	3.17e-05	0.0275	CbGpPWpGaD
Raloxifene—ESR2—SIDS Susceptibility Pathways—GCK—gestational diabetes	2.9e-05	0.0252	CbGpPWpGaD
Raloxifene—ESR1—FOXA1 transcription factor network—AR—gestational diabetes	2.86e-05	0.0248	CbGpPWpGaD
Raloxifene—ESR1—Nuclear Receptor transcription pathway—AR—gestational diabetes	2.54e-05	0.0221	CbGpPWpGaD
Raloxifene—ESR2—SIDS Susceptibility Pathways—AR—gestational diabetes	2.06e-05	0.0179	CbGpPWpGaD
Raloxifene—CYP2B6—Biological oxidations—GGCT—gestational diabetes	2.04e-05	0.0177	CbGpPWpGaD
Raloxifene—EBP—Metabolism—GGCT—gestational diabetes	1.89e-05	0.0164	CbGpPWpGaD
Raloxifene—ESR1—Regulation of nuclear SMAD2/3 signaling—AR—gestational diabetes	1.76e-05	0.0152	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	1.75e-05	0.0152	CbGpPWpGaD
Raloxifene—CYP2C8—Biological oxidations—GGCT—gestational diabetes	1.73e-05	0.015	CbGpPWpGaD
Raloxifene—EBP—Metabolism—GLS2—gestational diabetes	1.66e-05	0.0144	CbGpPWpGaD
Raloxifene—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	1.65e-05	0.0143	CbGpPWpGaD
Raloxifene—CYP2B6—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	1.63e-05	0.0141	CbGpPWpGaD
Raloxifene—HTR6—GPCRs, Class A Rhodopsin-like—MTNR1B—gestational diabetes	1.48e-05	0.0128	CbGpPWpGaD
Raloxifene—EBP—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	1.48e-05	0.0128	CbGpPWpGaD
Raloxifene—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	1.39e-05	0.0121	CbGpPWpGaD
Raloxifene—CYP2C8—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	1.38e-05	0.0119	CbGpPWpGaD
Raloxifene—HTR2B—GPCRs, Class A Rhodopsin-like—MTNR1B—gestational diabetes	1.35e-05	0.0117	CbGpPWpGaD
Raloxifene—ESR1—Leptin signaling pathway—LEP—gestational diabetes	1.34e-05	0.0117	CbGpPWpGaD
Raloxifene—CYP2B6—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	1.34e-05	0.0116	CbGpPWpGaD
Raloxifene—HTR6—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	1.27e-05	0.011	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—AR—gestational diabetes	1.19e-05	0.0103	CbGpPWpGaD
Raloxifene—HTR2B—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	1.16e-05	0.01	CbGpPWpGaD
Raloxifene—CYP2C8—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	1.13e-05	0.00981	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—CYP19A1—gestational diabetes	1.1e-05	0.00952	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—AR—gestational diabetes	1.07e-05	0.00926	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—GGCT—gestational diabetes	1.05e-05	0.00911	CbGpPWpGaD
Raloxifene—HTR6—GPCR ligand binding—MTNR1B—gestational diabetes	9.66e-06	0.00838	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	9.58e-06	0.00832	CbGpPWpGaD
Raloxifene—CYP3A4—Biological oxidations—GGCT—gestational diabetes	9.26e-06	0.00804	CbGpPWpGaD
Raloxifene—CYP3A4—Tryptophan metabolism—CYP19A1—gestational diabetes	9.26e-06	0.00803	CbGpPWpGaD
Raloxifene—ESR1—Aryl Hydrocarbon Receptor—TNF—gestational diabetes	9.19e-06	0.00798	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—GLS2—gestational diabetes	9.17e-06	0.00796	CbGpPWpGaD
Raloxifene—EBP—Metabolism—NAMPT—gestational diabetes	9.07e-06	0.00787	CbGpPWpGaD
Raloxifene—EBP—Metabolism—GCK—gestational diabetes	9.01e-06	0.00782	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	8.84e-06	0.00768	CbGpPWpGaD
Raloxifene—HTR2B—GPCR ligand binding—MTNR1B—gestational diabetes	8.81e-06	0.00765	CbGpPWpGaD
Raloxifene—ESR2—Generic Transcription Pathway—AR—gestational diabetes	8.71e-06	0.00756	CbGpPWpGaD
Raloxifene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	7.48e-06	0.0065	CbGpPWpGaD
Raloxifene—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	7.39e-06	0.00641	CbGpPWpGaD
Raloxifene—CYP2B6—Biological oxidations—CYP19A1—gestational diabetes	7.09e-06	0.00616	CbGpPWpGaD
Raloxifene—CYP2B6—Metapathway biotransformation—CYP19A1—gestational diabetes	6.99e-06	0.00607	CbGpPWpGaD
Raloxifene—ESR2—SIDS Susceptibility Pathways—TNF—gestational diabetes	6.86e-06	0.00595	CbGpPWpGaD
Raloxifene—AOX1—Disease—RBP4—gestational diabetes	6.69e-06	0.00581	CbGpPWpGaD
Raloxifene—EBP—Metabolism—CYP19A1—gestational diabetes	6.59e-06	0.00572	CbGpPWpGaD
Raloxifene—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	6.07e-06	0.00527	CbGpPWpGaD
Raloxifene—CYP2C8—Biological oxidations—CYP19A1—gestational diabetes	6e-06	0.00521	CbGpPWpGaD
Raloxifene—AOX1—Disease—NAMPT—gestational diabetes	6e-06	0.00521	CbGpPWpGaD
Raloxifene—AOX1—Disease—GCK—gestational diabetes	5.96e-06	0.00518	CbGpPWpGaD
Raloxifene—CYP2C8—Metapathway biotransformation—CYP19A1—gestational diabetes	5.92e-06	0.00514	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	5.83e-06	0.00506	CbGpPWpGaD
Raloxifene—ESR1—Signaling by ERBB4—FGF2—gestational diabetes	5.8e-06	0.00503	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—MTNR1B—gestational diabetes	5.46e-06	0.00474	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—GGCT—gestational diabetes	5.43e-06	0.00471	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—NAMPT—gestational diabetes	5.03e-06	0.00436	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—GCK—gestational diabetes	4.99e-06	0.00434	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—MTNR1B—gestational diabetes	4.98e-06	0.00432	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—MTNR1B—gestational diabetes	4.96e-06	0.0043	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	4.83e-06	0.00419	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—GLS2—gestational diabetes	4.74e-06	0.00412	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—MTNR1B—gestational diabetes	4.52e-06	0.00393	CbGpPWpGaD
Raloxifene—ESR1—Generic Transcription Pathway—AR—gestational diabetes	4.39e-06	0.00381	CbGpPWpGaD
Raloxifene—ESR2—Gene Expression—AR—gestational diabetes	4.19e-06	0.00364	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—LEPR—gestational diabetes	3.7e-06	0.00321	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—CYP19A1—gestational diabetes	3.65e-06	0.00317	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—GGCT—gestational diabetes	3.49e-06	0.00303	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—LEPR—gestational diabetes	3.38e-06	0.00293	CbGpPWpGaD
Raloxifene—CYP3A4—Biological oxidations—CYP19A1—gestational diabetes	3.22e-06	0.0028	CbGpPWpGaD
Raloxifene—CYP3A4—Metapathway biotransformation—CYP19A1—gestational diabetes	3.18e-06	0.00276	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—GLS2—gestational diabetes	3.05e-06	0.00264	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—GGCT—gestational diabetes	2.95e-06	0.00256	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	2.94e-06	0.00255	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—MTNR1B—gestational diabetes	2.93e-06	0.00254	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—RBP4—gestational diabetes	2.85e-06	0.00248	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—LEPR—gestational diabetes	2.82e-06	0.00244	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—MTNR1B—gestational diabetes	2.67e-06	0.00232	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—RBP4—gestational diabetes	2.6e-06	0.00226	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—NAMPT—gestational diabetes	2.6e-06	0.00226	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—GCK—gestational diabetes	2.58e-06	0.00224	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—GLS2—gestational diabetes	2.58e-06	0.00224	CbGpPWpGaD
Raloxifene—AOX1—Disease—FGF2—gestational diabetes	2.32e-06	0.00201	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	2.31e-06	0.002	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—MTNR1B—gestational diabetes	2.23e-06	0.00193	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—RBP4—gestational diabetes	2.17e-06	0.00188	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—AR—gestational diabetes	2.12e-06	0.00184	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—NAMPT—gestational diabetes	1.67e-06	0.00145	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—GCK—gestational diabetes	1.66e-06	0.00144	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GGCT—gestational diabetes	1.58e-06	0.00137	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—NAMPT—gestational diabetes	1.41e-06	0.00123	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—GCK—gestational diabetes	1.4e-06	0.00122	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GLS2—gestational diabetes	1.38e-06	0.0012	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—LEP—gestational diabetes	1.3e-06	0.00113	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—CYP19A1—gestational diabetes	1.21e-06	0.00105	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—LEP—gestational diabetes	1.19e-06	0.00103	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—CYP19A1—gestational diabetes	1.03e-06	0.000891	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—LEP—gestational diabetes	9.89e-07	0.000858	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—FGF2—gestational diabetes	9.88e-07	0.000858	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—FGF2—gestational diabetes	9.02e-07	0.000783	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—NAMPT—gestational diabetes	7.59e-07	0.000658	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GCK—gestational diabetes	7.54e-07	0.000654	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—FGF2—gestational diabetes	7.51e-07	0.000652	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CYP19A1—gestational diabetes	5.51e-07	0.000478	CbGpPWpGaD
